Drug
Cromolyn Sodium
Cromolyn Sodium is a pharmaceutical drug with 7 clinical trials. Historical success rate of 66.7%.
Total Trials
7
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 4 completed trials
Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
2(29%)
Phase Distribution
Ph early_phase_1
1
14%
Ph phase_2
2
29%
Ph phase_1
3
43%
Ph phase_3
1
14%
Phase Distribution
4
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
3(42.9%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
7
all time
Status Distribution
Active(1)
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (14.3%)
Phase 13 (42.9%)
Phase 22 (28.6%)
Phase 31 (14.3%)
Trials by Status
not_yet_recruiting114%
terminated229%
completed457%
Recent Activity
0 active trials
Showing 5 of 7
not_yet_recruitingphase_2
Mast Cell Treatment in Post-tick Bite Illness (PTBI)
NCT07526558
completedearly_phase_1
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
NCT03167216
terminatedphase_3
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
NCT05077917
completedphase_1
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
NCT01933464
terminatedphase_1
Cromolyn Detection of Silent Aspiration
NCT01841307
Clinical Trials (7)
Showing 7 of 7 trials
NCT07526558Phase 2
Mast Cell Treatment in Post-tick Bite Illness (PTBI)
NCT03167216Early Phase 1
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction
NCT05077917Phase 3
Cromolyn Sodium for Treatment of COVID-19 Pneumonia
NCT01933464Phase 1
An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
NCT01841307Phase 1
Cromolyn Detection of Silent Aspiration
NCT02566252Phase 1
Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)
NCT00745199Phase 2
Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7